The prioritization and identification of disease-causing mutations is one of the most significant challenges in medical genomics. Currently available methods address this problem for non-synonymous single nucleotide variants (SNVs) and variation in promoters/enhancers, however, recent research has implicated synonymous (silent) exonic mutations in a number of disorders.